IRB Study Number 21-799
Status Recruiting
Location Cleveland Clinic Main Campus
Institute Heart and Vascular Institute
Description
The registry will focus on furthering the understanding of the natural history of recurrent pericarditis (RP), as well as document RP-related clinical, health-related quality of life (HRQoL), and economic burden and will assist the medical community to refine or develop data-driven recommendations for clinical management of RP patients to optimize clinical outcomes. It also aims to generate data in support of the impact of rilonacept on clinical outcomes in a real-world population.
This is a US, non-interventional, registry for adult patients with recurrent pericarditis.
Inclusion Criteria
- Diagnosis of recurrent pericarditis
- Experienced at least one episode of RP within the last 3 years
- Currently prescribed medication for RP
Exclusion Criteria
A cognitive, visual, or hearing impairment which may interfere with patient questionnaires
Currently enrolled in an investigational drug or device trial
RP secondary to tuberculosis, cancer, blunt force trauma, myocarditis, systemic autoimmune diseases, HIV
